title: Biosensor-based small molecule fragment screening with biolayer interferometry.
abstract: Biosensor-based fragment screening is a valuable tool in the drug discovery process. This method is advantageous over many biochemical methods because primary hits can be distinguished from non-specific or non-ideal interactions by examining binding profiles and responses, resulting in reduced false-positive rates. Biolayer interferometry (BLI), a technique that measures changes in an interference pattern generated from visible light reflected from an optical layer and a biolayer containing proteins of interest, is a relatively new method for monitoring small molecule interactions. The BLI format is based on a disposable sensor that is immersed in 96-well or 384-well plates. BLI has been validated for small molecule detection and fragment screening with model systems and well-characterized targets where affinity constants and binding profiles are generally similar to those obtained with surface plasmon resonsance (SPR). Screens with challenging targets involved in protein-protein interactions including BCL-2, JNK1, and eIF4E were performed with a fragment library of 6,500 compounds, and hit rates were compared for these targets. For eIF4E, a protein containing a PPI site and a nucleotide binding site, results from a BLI fragment screen were compared to results obtained in biochemical HTS screens. Overlapping hits were observed for the PPI site, and hits unique to the BLI screen were identified. Hit assessments with SPR and BLI are described.
authors.affiliation: Discovery Technologies, Hoffman-La Roche, Nutley, NJ, USA. charles.wartchow@roche.com
authors.forename: Charles A
authors.initials: CA
authors.lastname: Wartchow
authors.forename: Frank
authors.initials: F
authors.lastname: Podlaski
authors.forename: Shirley
authors.initials: S
authors.lastname: Li
authors.forename: Karen
authors.initials: K
authors.lastname: Rowan
authors.forename: Xiaolei
authors.initials: X
authors.lastname: Zhang
authors.forename: David
authors.initials: D
authors.lastname: Mark
authors.forename: Kuo-Sen
authors.initials: KS
authors.lastname: Huang
mesh_terms: D001665:Binding Sites; D015374:Biosensing Techniques; D055808:Drug Discovery; D039561:Eukaryotic Initiation Factor-4E / Q000737:chemistry; D057166:High-Throughput Screening Assays; D006801:Humans; D007368:Interferometry / Q000379:methods; D048055:Mitogen-Activated Protein Kinase 8 / Q000737:chemistry; D011485:Protein Binding; D054852:Small Molecule Libraries / Q000145:classification*; D020349:Surface Plasmon Resonance
chemical_list: D039561:Eukaryotic Initiation Factor-4E; D054852:Small Molecule Libraries; D048055:Mitogen-Activated Protein Kinase 8